[1] It was the first pulmonary hypertension specific questionnaire for assessing patient reported symptoms, quality of life and functioning.
[5] The CAMPHOR is made up of 3 main dimensions which assess symptoms, functioning and quality of life (QoL).
The QoL scale has 25 items which focus on socialization, role, acceptance, self-esteem, independence, and security.
[7] Since the development of the CAMPHOR, it has been translated and validated into fourteen different languages,[8] including Australian and New Zealand English,[9] German[10] and Swedish.
[11] The Cambridge Pulmonary Hypertension Outcome Review has been a useful tool in clinical trials as it allows researchers to assess whether new medication or therapy is effective.